Glycosylation in Neurodegeneration

Glycosylation in Neurodegeneration

Introduction

Glycosylation is one of the most common and complex post-translational modifications, playing crucial roles in protein folding, stability, cell-cell recognition, and signaling. This page explores how glycosylation abnormalities contribute to neurodegenerative diseases.

Glycosylation involves the enzymatic attachment of carbohydrate moieties (glycans) to proteins or lipids. Approximately 50-70% of human proteins are glycosylated, making it one of the most prevalent post-translational modifications. In the nervous system, glycosylation is essential for synaptic function, neural development, and protein quality control. [@glycosylation2018]

Types of Glycosylation

N-Linked Glycosylation

Glycosylation in Neurodegeneration

Introduction

Glycosylation is one of the most common and complex post-translational modifications, playing crucial roles in protein folding, stability, cell-cell recognition, and signaling. This page explores how glycosylation abnormalities contribute to neurodegenerative diseases.

Glycosylation involves the enzymatic attachment of carbohydrate moieties (glycans) to proteins or lipids. Approximately 50-70% of human proteins are glycosylated, making it one of the most prevalent post-translational modifications. In the nervous system, glycosylation is essential for synaptic function, neural development, and protein quality control. [@glycosylation2018]

Types of Glycosylation

N-Linked Glycosylation

N-linked glycosylation occurs on asparagine residues within the consensus sequence Asn-X-Ser/Thr. This process begins in the endoplasmic reticulum (ER) and continues in the Golgi apparatus.

High-mannose type: Contains only mannose residues on the core chitobiose unit. This form is typically found on ER-resident proteins and serves as a quality control checkpoint.

Complex type: Contains additional sugars including N-acetylglucosamine (GlcNAc), galactose, fucose, and sialic acid. These are the most diverse N-glycans and are predominant on cell surface proteins.

Hybrid type: Combines features of high-mannose and complex types, with mannose residues on one branch and complex sugars on others.

The N-glycan processing pathway begins in the ER with the removal of glucose residues from the initial Glc3Man9Glc2 structure, followed by trimming in the Golgi to generate the various glycoforms. [@nlinked2020]

O-Linked Glycosylation

O-linked glycosylation occurs on serine or threonine residues, typically in the Golgi apparatus. Unlike N-glycosylation, there is no strict consensus sequence, making prediction more challenging.

Mucin-type O-glycans: Core 1 (Galβ1-3GalNAcα1-Ser/Thr) and core 2 (Galβ1-3(GlcNAcβ1-6)GalNAcα1-Ser/Thr) are the most common. Extended mucin-type glycans can become very large and heavily sialylated.

O-GlcNAc: A single N-acetylglucosamine attached to serine or threonine residues on nuclear and cytoplasmic proteins. Unlike other O-glycans, O-GlcNAc is reversible and dynamic, serving as a nutrient and stress sensor. The enzymes O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) regulate this modification. [@oglcnac2021]

Fucose and xylose linkages: Found on extracellular matrix proteins and growth factor receptors. These modifications are crucial for ligand binding and receptor activation.

Other Glycosylation Types

C-mannosylation: Rare modification on tryptophan residues within the consensus sequence Trp-X-X-Trp. Found in proteins with thrombospondin-type repeats.

Glypiation: GPI anchor attachment for membrane proteins. The GPI anchor is synthesized in the ER and added to the C-terminus of proteins, anchoring them to the plasma membrane.

Glycosaminoglycans: Long, unbranched polysaccharides including heparan sulfate, chondroitin sulfate, and keratan sulfate, attached to core proteins to form proteoglycans.

Glycosylation in the Nervous System

Synaptic Glycoproteins

Numerous synaptic proteins are heavily glycosylated, and proper glycosylation is essential for their function:

Synaptic cell adhesion molecules (SynCAM): Require proper glycosylation for homophilic interactions across the synaptic cleft. The glycan modifications on SynCAM affect its ability to induce synapse formation.

Neuroligins and neurexins: Glycosylation affects synaptic adhesion strength and specificity. Alternative splicing creates isoforms with different glycan profiles.

AMPA and NMDA receptor subunits: Glycosylation influences trafficking, localization, and function. NMDA receptor glycosylation affects channel properties and synaptic plasticity. [@nmda2019]

GluA1-4 (AMPA receptors): Differ in their glycan composition, affecting their trafficking and synaptic retention.

Glycosylation in Myelin

Myelin proteins contain unique glycosylation patterns essential for white matter integrity:

Myelin oligodendrocyte glycoprotein (MOG): Heavily glycosylated on its extracellular domain. MOG is a major autoantigen in multiple sclerosis and its glycosylation status affects antibody recognition.

Myelin basic protein (MBP): Contains unique glycosylation that affects its membrane association and compaction properties.

Proteolipid protein (PLP): Modified with glycans that affect its trafficking to myelin sheaths. [@myelin2022]

Glycosyltransferases in the Brain

Brain-expressed glycosyltransferases are essential for neural development and function:

ST8Sia2 (STX): Alpha-2,8-sialyltransferase involved in polysialic acid (PSA) synthesis on neural cell adhesion molecule (NCAM). PSA-NCAM is crucial for synaptic plasticity and neural migration.

B3GAT3: Beta-1,3-glucuronyltransferase involved in glycosaminoglycan synthesis.

MGAT5: N-acetylglucosaminyltransferase V, responsible for creating beta-1,6-GlcNAc branches on N-glycans. This enzyme is involved in tumor metastasis and immune cell function.

POMGNT1 and POMT1: Protein O-mannosyltransferases required for the glycosylation of alpha-dystroglycan, essential for muscle and brain development.

Glycosylation Dysfunction in Neurodegenerative Diseases

Alzheimer's Disease

Multiple glycosylation abnormalities have been documented in Alzheimer's disease:

APP Glycosylation

Proper glycosylation affects amyloid precursor protein (APP) processing and amyloid-beta (Aβ) generation. The glycosylation status of APP influences its trafficking through the secretory pathway and its susceptibility to proteolytic cleavage by β- and γ-secretases. [@app2017]

• N-glycosylation of APP at Asn28 affects Aβ generation
• O-GlcNAc modification of APP regulates its turnover
• Glycosylation changes in AD brains lead to altered APP processing

Tau protein undergoes extensive glycosylation in the brain. In AD:

• O-GlcNAc modification of tau is reduced in AD
• Abnormal O-linked glycosylation increases in disease
• Glycosylated tau shows altered aggregation properties [@tau2020]

β-secretase (BACE1) requires proper glycosylation for its catalytic activity. Changes in BACE1 glycosylation in AD may affect amyloid production.

Synaptic Glycoprotein Changes

• Altered sialylation of synaptic proteins
• Changes in glycan structures on NMDA and AMPA receptors
• Reduced polysialylation of NCAM in AD brains

Parkinson's Disease

Alpha-Synuclein Glycosylation

Alpha-synuclein (α-syn) is modified by O-GlcNAc, which may regulate its aggregation:

• O-GlcNAc modification reduces α-syn aggregation
• Phosphorylation at Ser129 and O-GlcNAc may compete
• Glycosylation affects Lewy body formation [@alphasynuclein2019]

Proper glycosylation of lysosomal enzymes is essential for their trafficking and function. In PD:

• Glucocerebrosidase (GCase) glycosylation affects its activity
• Mutations in glycosylation genes (e.g., GBA) increase PD risk

Amyotrophic Lateral Sclerosis (ALS)

TDP-43 Glycosylation

TDP-43 is the major component of inclusions in ALS. Glycosylation of TDP-43:

• Affects its aggregation propensity
• May serve as a pathological marker
• Creates unique epitopes for antibody recognition [@tdp2021]

• Altered O-GlcNAc homeostasis in motor neurons
• Changes in sialylation of neuronal surfaces

Huntington's Disease

Huntingtin Glycosylation

The huntingtin protein contains multiple glycosylation sites:

• N-glycosylation affects protein localization
• O-GlcNAc modification may regulate aggregation
• Glycosylation changes correlate with disease progression [@huntingtin2022]

Glycosylation and Protein Quality Control

ER-Associated Degradation (ERAD)

Glycosylation plays a crucial role in protein quality control:

N-glycan-based quality control

• Glucose trimming signals proper folding
• Mannose trimming signals misfolded proteins for degradation
• EDEM family members recognize misfolded glycoproteins

• Calnexin and calreticulin recognize partially folded glycoproteins
• OS-9 and XTP3-B target misfolded proteins for degradation

Autophagy and Glycosylation

Glycan involvement in autophagy

• Selective autophagy receptors contain glycan-binding domains
• Aggresome-like induced structures (ALIS) contain glycosylated proteins
• Glycan modifications affect protein clearance [@glycosylation2023]

Therapeutic Implications

Targeting Glycosylation Pathways

Enzyme inhibitors

• Mannosidase inhibitors: Reduce aberrant N-glycosylation
• Sialidase inhibitors: Modulate sialylation patterns
• O-GlcNAcase inhibitors: Increase O-GlcNAc modification

• Glycomimetics: Small molecules targeting glycan-binding proteins
• Lectin antagonists: Block pathological glycan interactions
• Glycan epitopes as vaccines

Nutritional Approaches

Dietary influences on glycosylation

• Dietary sugars affect glycosylation patterns
• Sugar nucleotides availability limits glycosylation capacity
• Fasting and caloric restriction affect O-GlcNAc [@dietary2024]

• N-acetylglucosamine (GlcNAc): Enhances O-GlcNAc
• Mannose: May improve protein folding
• Sialic acid precursors: Support synaptic function

Gene Therapy Approaches

Glycosyltransferase modulation

• Overexpression of beneficial glycosyltransferases
• Suppression of pathological glycan structures
• Targeting specific glycan epitopes

Biomarkers Based on Glycosylation

Blood-Based Biomarkers

Glycan biomarkers

• Altered serum glycan profiles in neurodegeneration
• Specific glycan changes correlate with disease stage
• Glycosylation of neuronal proteins in plasma

• Identification of disease-specific glycoforms
• Quantification of specific glycoproteins
• Changes in glycan structure as biomarkers [@glycan2024]

CSF Biomarkers

• Glycosylated tau species
• Glycosylated amyloid-beta
• Neuronal glycoprotein fragments

Animal Models of Glycosylation Dysfunction

Genetic Models

Glycosyltransferase knockouts

• MGAT5 knockout: Enhanced neuronal sensitivity
• ST8Sia2 knockout: Reduced NCAM polysialylation
• OGT knockdown: Altered O-GlcNAc homeostasis

• Congenital disorders of glycosylation (CDG): Neurological phenotypes
• Dystroglycanopathy models: Muscle and brain involvement

Induced Models

• Streptozotocin-induced diabetes: O-GlcNAc reduction
• Kynurenine administration: Sialylation changes

Future Directions

Glycomics Technologies

Analysis methods

• Mass spectrometry-based glycomics
• Glycan microarrays
• Lectin arrays for glycan profiling

• Cell-type specific glycosylation patterns
• Spatial glycan mapping in brain

Clinical Applications

Personalized glycomedicine

• Glycan-based patient stratification
• Glycosylation as treatment response marker
• Individualized glycosylation-targeting therapies

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Huntington's Disease](/diseases/huntingtons)
• [Protein Aggregation](/mechanisms/protein-aggregation)
• [ER Stress](/mechanisms/endoplasmic-reticulum-stress)
• [Autophagy](/mechanisms/lysosomal-dysfunction)
• [Synaptic Dysfunction](/mechanisms/synaptic-plasticity-deficits)
• [Neuroinflammation](/mechanisms/microglia-neuroinflammation)